首页> 外文期刊>Genetic Engineering & Biotechnology News: The Information Source of the Biotechnology Industry >IsoSpark, IsoLight, and IsoSpark DuoAccelerating the Next Big Breakthrough in Immune Medicine
【24h】

IsoSpark, IsoLight, and IsoSpark DuoAccelerating the Next Big Breakthrough in Immune Medicine

机译:IsoSpart,isolight和isospart Duo加速了免疫医学的下一个大突破

获取原文
获取原文并翻译 | 示例
           

摘要

Researchers urgently need new approaches for functional immune profiling in order to accelerate discovery and development of curative medicines.From its inception, IsoPlexis'mission has been to harness the most powerful cells to personalize immune medicine and make their groundbreaking functional immune profiling technology and unique applications accessible to virtually every laboratory worldwide. Functional phenotyping data from their single-cell proteomics hubs have been used to investigate cancer immunology, infectious disease and vaccines, cell and gene therapy, inflammation, neurology, and targeted therapies.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号